CoNextions Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Employees
  • 10
Employees
  • Latest Deal Type
  • Series C
  • Latest Deal Amount
  • $3.73M
Latest Deal Amount
  • Investors
  • 2

CoNextions General Information

Description

Developer of rapid tendon repair technology designed to provide tendon repair outcomes. The company's technology is dedicated to achieving safe, strong and durable tendon repairs marked by rehabilitation, fewer complications and lower long-term costs, enabling physicians to repair tendons in less time than it takes to suture.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Primary Office
  • 150 North Wright Brothers Drive
  • Suite 560
  • Salt Lake City, UT 84116
  • United States
+1 (385) 000-0000

CoNextions Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CoNextions Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series C) 16-Dec-2020 $3.73M 000.00 000.00 Completed Generating Revenue
6. Later Stage VC 25-Apr-2019 00.000 000.00 Completed Generating Revenue
5. Later Stage VC (Series B) 26-Dec-2018 00.000 000.00 000.00 Completed Generating Revenue
4. Later Stage VC (Series A1) 28-Mar-2017 00.000 00.000 000.00 Completed Generating Revenue
3. Later Stage VC (Series A) 09-Aug-2016 00.00 00.000 000.00 Completed Generating Revenue
2. Angel (individual) 21-Jul-2014 $150K $170K Completed Startup
1. Angel (individual) 19-Dec-2013 $20K $20K Completed Startup
To view CoNextions’s complete valuation and funding history, request access »

CoNextions Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Series B 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A1 814,494 $0.001000 $2.66 $2.66 1x $2.66 5.61%
Series A 608,273 $0.001000 $4.11 $4.11 1x $4.11 4.19%
To view CoNextions’s complete cap table history, request access »

CoNextions Executive Team (8)

Name Title Board Seat Contact Info
Jeffrey Barnes Co-Chief Executive Officer, President & Board Member
Richard Linder Co-Founder, President, Co-Chief Executive Officer & Chairman of the Medical Advisory Board
Brian Woolf Chief Financial Officer & Treasurer
Jeff Hockersmith Director, Quality
Erik Kubiak MD Co-Founder, Chairman & Director
You’re viewing 5 of 8 executive team members. Get the full list »

CoNextions Board Members (11)

Name Representing Role Since
Ben Widmer MD CoNextions Board Member 000 0000
Charles Saltzman MD CoNextions Board Member 000 0000
Christopher Peters MD CoNextions Board Member 000 0000
Erik Kubiak MD CoNextions Co-Founder, Chairman & Director 000 0000
Florian Nickisch MD CoNextions Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

CoNextions Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CoNextions Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BioVentures Investors Venture Capital Minority 000 0000 000000 0
Kickstart Seed Fund Venture Capital Minority 000 0000 000000 0
To view CoNextions’s complete investors history, request access »